Company profile: Desert Tox
1.1 - Company Overview
Company description
- Provider of SAMHSA-certified laboratory testing services, offering workplace forensic drug and alcohol testing; DOT and non-DOT services (pre-employment, reasonable suspicion, return to duty, random, post-accident, follow-up); customizable panels; DOT-approved alcohol testing by certified technicians; and support for drug-free workplace programs.
Products and services
- DOT and Non-DOT Testing Services: Delivers DOT-compliant testing portfolios spanning pre-employment, reasonable suspicion, return-to-duty, random, post-accident, and follow-up assessments across DOT and non-DOT programs
- Alcohol Testing Procedures: Offers DOT-approved devices operated by certified technicians, ensuring accurate alcohol measurements and compliance in workplace testing programs
- Workplace Forensic Drug and Alcohol Testing: Engineers SAMHSA-certified forensic testing for workplace environments, verifying drug and alcohol use while supporting adherence to regulations and internal company policies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Desert Tox
Clinical Laboratory of the Black Hills
HQ: United States
Website
- Description: Provider of anatomic pathology services to meet the needs of clients and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Laboratory of the Black Hills company profile →
ProPath
HQ: United States
Website
- Description: Provider of a pathology practice run entirely by physicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProPath company profile →
Hexarad
HQ: United Kingdom
Website
- Description: Provider of tech-enabled teleradiology supporting remote reporting of medical scans such as CTs, MRIs and X-rays. Offers the Hexarad Platform for radiology solutions with fast and accurate diagnosis through remote reporting; ReportRad for access to subspecialist radiologists for routine, urgent and out-of-hours reporting; OptiRad workflow management software; and the Hexarad Thought Leadership Institute.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hexarad company profile →
Viracor-IBT
HQ: United States
Website
- Description: Provider of specialty diagnostics laboratory services in allergy, immunology and infectious disease testing, delivering tests, results and support to doctors and hospitals to enable optimal care, and collaborating with pharmaceutical researchers to address complex challenges.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Viracor-IBT company profile →
Dianon
HQ: United States
Website
- Description: Provider of urology diagnostic services, including prostate and bladder testing, specialty biopsy services, and microhematuria assessment. Offers a broad array of pathology testing procedures with academic-based expertise and the personal service of a local pathologist, including dermatopathology, gastrointestinal pathology, and uropathology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dianon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Desert Tox
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Desert Tox
2.2 - Growth funds investing in similar companies to Desert Tox
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Desert Tox
4.2 - Public trading comparable groups for Desert Tox
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →